Health insurance company Oscar Health (NYSE: OSCR) will be reporting results this Tuesday before market open. Here’s what to expect.

Oscar Health missed analysts’ revenue expectations by 3.3% last quarter, reporting revenues of $2.99 billion, up 23.3% year on year. It was a mixed quarter for the company, with full-year operating income guidance exceeding analysts’ expectations but a significant miss of analysts’ revenue estimates.

Is Oscar Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Oscar Health’s revenue to grow 30.6% year on year to $3.12 billion, slowing from the 67.1% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.92 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Oscar Health has missed Wall Street’s revenue estimates four times over the last two years.

Looking at Oscar Health’s peers in the health insurance providers segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Cigna delivered year-on-year revenue growth of 10.4%, beating analysts’ expectations by 3.8%, and Centene reported revenues up 21.9%, topping estimates by 3%. Cigna traded up 7.5% following the results.

Read our full analysis of Cigna’s results here and Centene’s results here.

The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the health insurance providers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.1% on average over the last month. Oscar Health is down 29.9% during the same time and is heading into earnings with an average analyst price target of $15.78 (compared to the current share price of $12.38).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.